4-Methylumbelliferone (4-MU)

Catalog No.S2256

4-Methylumbelliferone (4-MU) Chemical Structure

Molecular Weight(MW): 176.17

4-Methylumbelliferone is a hyaluronic acid (HA) synthesis inhibitor with an IC50 of 0.4 mM.

Size Price Stock Quantity  
In DMSO USD 90 In stock
USD 70 In stock
USD 210 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Purity & Quality Control

Biological Activity

Description 4-Methylumbelliferone is a hyaluronic acid (HA) synthesis inhibitor with an IC50 of 0.4 mM.
Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
COS1 cells M{XVOmZ2dmO2aX;uJIF{e2G7 NFH3OG9C\2:waYP0bYMh[WO2aY\peJkhf2G|IHTleIVzdWmwZXSgbY4hS0:VMTDj[YxteyC2cnHud4Zm[3SnZDD3bZRpKEeDTDC0MXBRSVJiZ3HtcYEhemWlZYD0c5ItKEWFNUC9NE4xOjFizszN NYjPb2hROTJ4MUe5NlQ>
CV-1 cells NInV[o9HfW6ldHnvckBie3OjeR?= MoPKUYF5cW2jbDDy[ZBwenSncjDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKFCncn;4bZNwdWVicILvcIln\XKjdH;yJIFkfGm4YYTl[EBz\WOncITvdkBo[W2vYTDHZYw1KGOqaX3ldolkKGmwIITyZY5{cWWwdHz5JJRz[W6|ZnXjeIVlKEOYLUGgZ4VtdHNiYomg[pVv[3Srb37hcEBie3OjeTygSWM2OD1yLkC0N{DPxE1? NX3mZ4F3OTF5MkC4OVQ>
COS-1 cells M4XxSmZ2dmO2aX;uJIF{e2G7 MY\JckB3cXS{bzD0doFve2GldHn2ZZRqd25ib3[gbJVu[W5icHXyc5hqe2:vZTDwdo9tcW[ncnH0c5Ih[WO2aY\heIVlKHKnY3XweI9zKGejbX3hJI1m[XO3cnXkJIlvKFCSQWKtS2FNPCClaHnt[ZJq[yCFT2OtNUBk\WyuczygSWM2OD1yLkCyJO69VQ>? NIfI[20yOjh5M{WxOy=>
CV-1 cells MnnGSpVv[3Srb36gZZN{[Xl? NETJd4pC[3SrdnH0bY9vKG:oIIDldo95cXOxbXWgdJJwdGmoZYLheI9zKGGldHn2ZZRm\CC{ZXPldJRweiCpYX3tZUBu\WG|dYLl[EBjgSCrbnT1Z5Rqd25ib3[gOVAmKG:oIH3hfIlufW1iYXzrZYxqdmVicHjvd5Bp[XSjc3WgZYN1cX[rdImsJJRz[W6|ZnXjeIlwdiCjc4PhfUBqdiCFVj2xJINmdGy|LDDFR|UxRTBwMEi5NVMh|ryP Ml7vPVg{PjZ{MB?=
CV-1 cells NVrTXG5CTnWwY4Tpc44h[XO|YYm= NUO2NI9OUW5idnn0do8hfHKjboPjdolxfGmxbnHsJIFkfGm4YYTpc44hd2ZiUHXyc5hqe2:vZTDwdo9tcW[ncnH0c5Ih[WO2aY\heIVlKHKnY3XweI9zKGejbX3hJEhRWEGUKTDlfJBz\XO|ZXSgbY4hS1ZvMTDj[YxteyxiRVO1NF0xNjB4IN88US=> M1:2cFg2PzZ7MEe=
COS-1 cells NFfTU25HfW6ldHnvckBie3OjeR?= NY[3WWJPUW5idnn0do8h[WexbnnzeEBi[3Srdnn0fUB1\XO2ZXSg[o9zKHS{YX7zZYN1cX[jdHnvckBqdiCqdX3hckBRWEGUIHfhcY1iNUejbESgZ4hqdWW{aXOgR29UNTFiY3XscJMtKEWFNUC9NE4xOiEQvF2= NHi5fVEyOjd{OU[2PC=>
CV-1 cells NHnBcVlHfW6ldHnvckBie3OjeR?= MXTJckB3cXS{bzDleoFtfWG2aX;uJIFo[Wmwc4SgVnhTNWGucHjhM3BRSVJvZ3HtcYEhcW5iQ2[tNUBk\WyuczDifUBkd3S{YX7z[oVkfGmxbjDhd5NigSC5YYOg[IV1\XKvaX7l[EwhTUN3ME2wMlMzPSEQvF2= MnLxNVI6PTRyNkG=
HepG2 cells NYPtZWloTnWwY4Tpc44h[XO|YYm= NGWxXoRG\m[nY4TpeoUh[2:wY3XueJJifGmxbjDh[4FqdnO2IHj1cYFvKFCSQWLnZY1u[SCneIDy[ZN{\WRiaX6gTIVxTzJiY3XscJMtKEWFNUC9NE4xOzlizszN Mn;2NVYyODdzNUC=
Huh7 cells MkDsSpVv[3Srb36gZZN{[Xl? NVTDXIY1TnWwY4Tpc45idCCjY4Tpeol1gSCjdDDoeY1idiCSUFHSJIdidW2jIHnuJGh2cDdiY3XscJMh[nlidILhcpNi[3SrdnH0bY9vKGG|c3H5MEBGSzVyPUCuNlIh|ryP MljUNVY{PjZ4MEG=
Huh7 cells Ml\wSpVv[3Srb36gZZN{[Xl? MYDF[oZm[3Rib36gVHBCWiCpYX3tZUB1emGwc3HjeIl3[XSrb36gZYN1cX[rdImgbY4hUHWqNzDj[YxteyxiRVO1NF0xNjJ{IN88US=> MU[xOlQ2OTB6Nx?=
U2OS cells M36zR2Z2dmO2aX;uJIF{e2G7 NXHXWVZsTW[oZXP0JI9vKFCSQWLnZY1u[SC2cnHud4FkfGm4YYTpc44h[WO2aY\peJkhcW5iVULPV{Bk\WyuczygSWM2OD1yLkCzJO69VQ>? NVPYfGtnOTZ|MEC5OFQ>
CV1 cells NET5ZmJHfW6ldHnvckBie3OjeR?= MVfUdoFve2GldHn2ZZRqd25ib3[gVHBCWmejbX3hJIlvKEOYMTDj[YxteyxiRVO1NF0xNjB5NjFOwG0> Ml;XNVY5OjF5Nkm=
human keratinocytes Mn[5VJJwdGmoZYLheIlwdiCjc4PhfS=> NX\6ToNESW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDr[ZJifGmwb3P5eIV{NCCHQ{WwQVgh|ryP NGG4bpUyPjh{MUe2PS=>
HT29 cell M2LGd3Bzd2yrZnXyZZRqd25iYYPzZZk> MlfoRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCKVEK5JINmdGxibHnu[UwhTUN3ME20OUDPxE1? NITMbIIyPjh{MUe2PS=>
NIH3T3 cells NHzL[2ZHfW6ldHnvckBie3OjeR?= NWG3bFNqSWO2aY\peJkh[XRiaIXtZY4hWFCDUjDnZY1u[SC2cnHud4Zm[3SnZDDpckBPUUh|VEOgZ4VtdHNiYomgcJVkcW[ncnHz[UBi[3Srdnn0fUBie3OjeTygSWM2OD1yLkOyJO69VQ>? Mmf5NVY5PTRyOEW=
CV1 cells NHL4THlHfW6ldHnvckBie3OjeR?= NFf0bWNVemGwc3HjeIl3[XSrb36gc4YhcHWvYX6gVHBCWmejbX3hJIlvKEOYMTDj[YxteyCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUC9NE4{ODhizszN MXmxOlk4ODN7MR?=
Huh7 cells Mo\QSpVv[3Srb36gZZN{[Xl? NY\Cb4dkSWO2aY\peJkh[XRiaIXtZY4hWFCDUjDnZY1u[SCrbjDIeYg4KGOnbHzzJIJ6KHS{YX7zZYN1cX[jdHnvckBie3OjeTygSWM2OD1yLkKyJO69VQ>? MUKxO|A{PDF2OR?=
HepG2 cells NIrMUlVHfW6ldHnvckBie3OjeR?= MlzMRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFTKGejbX3hJIlvKGFiSHXwS|Ih[2WubIOgZpkhWFCDUj3HRWw1KHS{YX7zZYN1cX[jdHnvckBie3OjeTygSWM2OD1yLkG1PEDPxE1? NW\YT5VrOTZ7N{OzOVg>
HepG2 cells NVjnPYdKTnWwY4Tpc44h[XO|YYm= MYLB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXIh\2GvbXGgbY4hUGWyR{KgZ4VtdHNiYomgVHBCWi2JQVy0JJRz[W6|YXP0bZZifGmxbjDhd5NigSxiRVO1NF0xNjF3ON88US=> M1:5Z|E3QTd7M{Sx
CV1 cells NWXEfnJMTnWwY4Tpc44h[XO|YYm= NF3XPFFC[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEhcW5iQ2[xJINmdGy|LDDFR|UxRTBwM{C4JO69VQ>? M17tcVE4ODB3M{m0
HEK293 cells MXPGeY5kfGmxbjDhd5NigQ>? M{HqRWFkfGm4aYT5JIF1KGi3bXHuJIFlcXCxc3WgeIl{e3WnIGDQRXIh\2GvbXGg[ZhxemW|c3XkJIlvKEiHS{K5N{Bk\WyuczDifUBRWEGULVfBUFQhfHKjboPhZ5RqfmG2aX;uJIF{e2G7LDDFR|UxRTBwM{Gg{txO NEW0eGUyPzN2M{O3NS=>
rat L6 cells NXvsXopvTnWwY4Tpc44h[XO|YYm= MVLF[oZm[3Rib36g[oF1fHliYXPp[EBwgGmmYYTpc44hcW5icnH0JGw3KGOnbHzzMEBGSzVyPUWg{txO NEK4SpYyPzN2M{O3NS=>
HepG2 cells M3y0[WZ2dmO2aX;uJIF{e2G7 MVzB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYTDpckBJ\XCJMjDj[YxteyCkeTDQVGFTNUeDTESgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwQVAvODh{IN88US=> MW[xO|E2PzBzOR?=
CV1 cells NVLJeJR6TnWwY4Tpc44h[XO|YYm= MmHxRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFT[WyyaHGgbY4hS1ZzIHPlcIx{KGK7IFfBUFQhfHKjboPhZ5RqfmG2aX;uJIF{e2G7IHHmeIVzKDJ2IHjyd{whTUN3ME2zMlQ3KM7:TR?= NYe5PGVSOTd3MEeyNlU>
CV1 cells Ml;JSpVv[3Srb36gZZN{[Xl? NGjtZW9C\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZUBqdiCFVkGgZ4VtdHNiYomgS2FNPCC2cnHud4FkfGm4YYTpc44h[XO|YYmgZYZ1\XJiMkSgbJJ{NCCHQ{WwQVAvODNizszN M2TkRVE4PTB5MkK1
CV1 cells NGfXb2NHfW6ldHnvckBie3OjeR?= MnruRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFT\2GvbXGg[ZhxemW|c3XkJIlvKEOYMTDj[YxteyCkeTDy[YNmeHSxcjD0doFve2GldHn2ZZRqd25iYYPzZZktKEWFNUC9NE4{ODhizszN Mn7VNVgxOjlzN{i=
CV1 cells M{jzeWZ2dmO2aX;uJIF{e2G7 MYfB[49vcXO2IHHjeIl3cXS7IHH0JHBRSVKpYX3tZUBqdiCFVkGgZ4VtdHNiYomgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwQVAvOzB6IN88US=> NGrOWGgyPzF{OUeyOS=>
HEK293 cells MoTXSpVv[3Srb36gZZN{[Xl? M1ToWGFod26rc4SgZYN1cX[rdImgZZQhWFCDUnfhcY1iKHKnY3XweI9zKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMh[nliR1HMOEB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5yM{Wg{txO M4rvclE4Ojl{NkC2
NIH3T3 cells NIDaVWRHfW6ldHnvckBie3OjeR?= MV;B[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYTDlfJBz\XO|ZXSgbY4hVkmKM2SzJINmdGy|IHL5JGdCVDRidILhcpNi[3SrdnH0bY9vKGG|c3H5MEBGSzVyPUCuN|Ih|ryP M2\se|E4PjJ2N{e3
HEK293 cells NYflenhCTnWwY4Tpc44h[XO|YYm= MYnB[49vcXO2IHHjeIl3cXS7IHH0JHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzJIJ6KEeDTESgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwQVAvOTlizszN MX6xPFAzQTF5Nh?=
HEK293 cells NHfiU3RHfW6ldHnvckBie3OjeR?= MUDB[49vcXO2IHHjeIl3cXS7IHH0JHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzJIF{e2W|c3XkJIF{KGGSMjDn[Y5mKGmwZIXjeIlwdixiRVO1NF0xNjF{IN88US=> NYK3[pdQOThyMkmxO|Y>
HEK293 cells M{HZVWZ2dmO2aX;uJIF{e2G7 M{TXfWFod26rc4SgZYN1cX[rdImgZZQhWFCDUnfhcY1iKGmwIFjFT|I6OyClZXzsd{BjgSCJQVy0JJRz[W6|YXP0bZZifGmxbjDhd5NigSxiRVO1NF0xNjB2NTFOwG0> NIW3RXYyQDJ7MU[0OS=>
HepG2 cells NWr5[ZBKTnWwY4Tpc44h[XO|YYm= NV3ndXR6SWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUYXzwbIEhdGmpYX7kJIJqdmSrbneg[I9u[WmwIHX4dJJme3OnZDDpckBpfW2jbjDI[ZBIOiClZXzsd{Bkdy22cnHud4Zm[3SnZDD3bZRpKEejbESgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDFR|UxRTBwMEO5JO69VQ>? NI[4cHUyQDh|NUexPS=>
RAW264.7 cells NEnXZ49HfW6ldHnvckBie3OjeR?= NEWzOYFUfXCycnXzd4lwdiCxZjDMVHMwUU[QLXfhcY1iNXO2aX31cIF1\WRiTl:gdJJw\HWldHnvckBqdiCvb4Xz[UBTSVd{NkSuO{Bk\WyuczygSWM2OD1zNz61JO69VQ>? MYWxPFgxQTN{NR?=
BL21 cells M{Ky[2Z2dmO2aX;uJIF{e2G7 M{DwU2Rqe3CuYXPlcYVvfCCxZjDyZYRqdyCuYXLlcIVlKDJqUzmtLFIu[mWwen;5cE1xcGWweXzhcYlvdylvMz37OE1cOSxzLXTpeJJqfGmxLUKtLFUudWW2aInsMVIueGinbonsMY95[XqxbD20MZltMS2ndHjvfJleNXCqZX75cJ0ueHKxcHnvcolkKGGlaXSg[pJwdSCJU2St[pV{\WRiaIXtZY4hWFCDUnfhcY1iKGW6cILld5Nm\CCrbjDFd4Np\XKrY3jpZUBkd2yrIFLMNlEh[2WubIOgZpkhe2OrboTpcIxifGmxbjDwdo95cW2rdImgZZN{[XluIFXDOVA:OC52NTFOwG0> M1G3V|E6OzR7MUe2
BHK21 cells MUnGeY5kfGmxbjDhd5NigQ>? MVnB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYTDlfJBz\XO|ZXSgbY4hSkiNMkGgZ4VtdHNiYYPz[ZN{\WRiYYOgV2VCWCCjY4Tpeol1gSCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJJRz[W6|YXP0bZZifGmxbjDhd5NigSxiRVO1NF0xNjR3IN88US=> Mo\ENVk{PDlzN{[=
HepG2/C3A cells NV7DZmEyTnWwY4Tpc44h[XO|YYm= NEXhWGhC[3SrdnH0bY9vKG:oIHj1cYFvKFCSQWLnZY1u[SCuaXfhcoQh[mmwZHnu[{Bld22jaX6tcYVlcWG2ZXSgeJJidnOlcnnweIlwdmGuIHHjeIl3cXS7IHnuJIh2dWGwIFjldGczN0N|QTDj[YxteyClbz30doFve2[nY4Tl[EB4cXSqIH\1d4VlKEejbEStUGJFKGK7IHPveJJidnOoZXP0bY9vKGG|c3H5MEBGSzVyPUCuNFA{QCEQvF2= NWTaO45jOTd2MEO2PFg>
HepG2 cells MnvkSpVv[3Srb36gZZN{[Xl? NYLjZVlHSWexbnnzeEBi[3Srdnn0fUBifCCSUFHS[4FudWFiZYjwdoV{e2WmIHnuJIh2dWGwIFjldGczKGOnbHzzJIF{e2W|c3XkJIF{KGmwZIXjeIlwdiCxZjDy[YNmeHSxcjD0doFve2GldHn2ZZRqd25iYomgdoVxd3K2ZYKg[4Vv\SCjc4PhfUBz\WyjdHn2[UB1dyClb370do9tNCCHQ{WwQVAvODVizszN MljQNVg3OjV3NUm=
COS1 cells NIPNNJpHfW6ldHnvckBie3OjeR?= M{nFVmFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gdoVkd22kaX7hcpQhWFCDUnfhcY1iKGW6cILld5Nm\CCrbjDDU3MyKGOnbHzzJINwNWW6cILld5NqdmdiR1HMOEBie3Onc4Pl[EBieyC2cnHud4NzcXC2aX;uZYwh[WO2aY\peJkh[W[2ZYKgOFghcHK|IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSxiRVO1NF0xNjB{IN88US=> MmP3NVk2ODd6NkG=
HepG2 cells NFr5SmpHfW6ldHnvckBie3OjeR?= NWPvfIJzSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIFjldGczKGOnbHzzJIJ6KEeDTESgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwQVAvOjJ|IN88US=> NFPnNHgyQDN7NEmwOy=>
CV1 cells MlHCSpVv[3Srb36gZZN{[Xl? M3X3bWFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hJIxq\2GwZDDibY5lcW6pIHTvcYFqdiCneIDy[ZN{\WRiaX6gZYZzcWOjbjDndoVmdiCvb37r[ZkhS1ZzIHPlcIx{KGOxLYTyZY5{\mWldHXkJJdqfGhiZoXz[YQhT2GuND3ERmQh[nlidILhcpNi[3SrdnH0bY9vKGG|c3H5MEBGSzVyPUCuNFM{KM7:TR?= MX2xPFgzPjJyNR?=
CV1 cells M3HFemZ2dmO2aX;uJIF{e2G7 Mo\sRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFT[WyyaHGgcIlo[W6mIHLpcoRqdmdiZH;tZYlvKGW6cILld5Nm\CCrbjDh[pJq[2GwIHfy[YVvKG2xbnvlfUBEXjFiY3XscJMh[29vdILhcpNn\WO2ZXSge4l1cCCodYPl[EBI[Wx2LVTCSEBjgSC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;Mz60OkDPxE1? NWHUeGVROTh6Mk[yNFU>
U2OS cells M4faZmZ2dmO2aX;uJIF{e2G7 Mn[3RYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFT\2GvbXGgbY4hXTKRUzDj[YxteyCkeTD0doFve2GldHn2ZZRqd25iYYPzZZktKEWFNUC9NE4xOiEQvF2= NXXNWFlFOTh|Mkm3OVE>
Hep G2 cells M1;sVmZ2dmO2aX;uJIF{e2G7 MonwRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFT\2GvbXGgcIlo[W6mIHLpcoRqdmdiZH;tZYlvKGW6cILld5Nm\CCrbjDoeY1idiCKZYCgS|Ih[2WubIOgZ48ufHKjboPm[YN1\WRid3n0bEBI[Wx2LVTCSEBjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGVEPTB;MD6wOEDPxE1? NHvMeXQyQTB3M{e3Oi=>
HeLa cells MUTGeY5kfGmxbjDhd5NigQ>? Ml:yRYdwdmm|dDDhZ5Rqfmm2eTDheEBRWEGUZ3HtcYEhdGmpYX7kJIJqdmSrbneg[I9u[WmwIHX4dJJme3OnZDDpckBpfW2jbjDI[WxiKGOnbHzzJINwNXS{YX7z[oVkfGWmIIfpeIghT2GuND3ERmQh[XO|ZYPz[YQh[XNidILhcpNkemmydHnvcoFtKGGldHn2ZZRqd25iYomgS4FtPCC{ZYPwc45{\SCnbHXt[Y51NWS{aY\lckBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFXDOVA:OC5yMUWg{txO NYLjc2syOTl{N{W5OlM>
COS1 cells NEe5[5pHfW6ldHnvckBie3OjeR?= MVrB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYTDy[YNmeHSxcjDlfJBz\XO|ZXSgbY4h[W[{aXPhckBoemWnbjDtc45s\XliQ1;TNUBk\WyuczDjc{11emGwc3\lZ5Rm\CC5aYToJIZ2e2WmIInlZZN1KEejbEStSGJFKGK7IITyZY5{[WO2aY\heIlwdiCjc4PhfUwhTUN3ME2wMlAzKM7:TR?= M33BOlE6PTNyNkix
U2OS cells M4HT[mZ2dmO2aX;uJIF{e2G7 NHnLV3NC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iVULPV{Bk\WyuczDifUBtfWOrZnXyZZNmKHS{YX7zZYN1cX[jdHnvckBie3OjeTygSWM2OD1yLkC1JO69VQ>? M13jflE6PTd2MEW2
HepG2 cells MlTsSpVv[3Srb36gZZN{[Xl? NUP3TVEzSWexbnnzeEBi[3Srdnn0fUBifCCJQVy0MZRi\2enZDDoeY1idiCSUFHS[4FudWFibHnnZY5lKGKrbnTpcoch\G:vYXnuJIV5eHKnc4Pl[EBqdiCqdX3hckBJ\XCJMjDj[YxteyCjc4Pld5Nm\CCjczDy[YNmeHSxcjD0doFve2GldHn2ZZRqd25iYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwQVAvODN7IN88US=> M4TSe|E6Pzd3MU[5
HepG2 cells MUDGeY5kfGmxbjDhd5NigQ>? MXzB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYTDlfJBz\XO|ZXSgbY4hUGWyR{KgZ4VtdHNiYomgS2FNPCC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;MD6yNlMh|ryP MWmxPVc5OzR2NB?=
COS7 cells NGfYW5VHfW6ldHnvckBie3OjeR?= NXLFWohQSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBz\WOxbXLpcoFvfCCSUFHS[4FudWF{IFzCSEBmgHC{ZYPz[YQhcW5iYX\ybYNidiCpcnXlckBud26tZYmgR29UPyClZXzsd{Bkd2W6cILld5NqdmdiR1HMOEBjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUhfHKjboPhZ5RqfmG2aX;uJIF{e2G7LDDFR|UxRTBwMTFOwG0> NFzWNXozODF|OEe2Ni=>
COS7 cells NELYPI9HfW6ldHnvckBie3OjeR?= M{TEUmFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gdoVkd22kaX7hcpQhWFCDUnfhcY1iOSCOQlSg[ZhxemW|c3XkJIlvKGGocnnjZY4h\3KnZX6gcY9vc2W7IFPPV|ch[2WubIOgZ49mgHC{ZYPzbY5oKEeDTESgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJJRz[W6|YXP0bZZifGmxbjDhd5NigSxiRVO1NF0xNjB|IN88US=> MlezNlAyOzh5NkK=
HEK cells NEDIOplHfW6ldHnvckBie3OjeR?= NInpeVhC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJGdCVDRvdHHn[4VlKFCSQWLhcJBp[SClaHnt[ZJq[yC{ZXPldJRweiCneIDy[ZN{\WRiaX6gTGVMKGOnbHzzJIJ6KHS{YX7zZYN1cX[jdHnvckBie3OjeTygSWM2OD1zMD61PEDPxE1? M{XUR|IxOjl7MkG0
HEK cells MnzySpVv[3Srb36gZZN{[Xl? NVnNTYJHSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBISUx2LYTh[4dm\CCSUFHS[4FudWFiY3jpcYVzcWNicnXj[ZB1d3JiZYjwdoV{e2WmIHnuJGhGUyClZXzsd{BjgSC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;MD6wN|Uh|ryP NWLYeGRlOjB{OUmyNVQ>
3T3L1 cells M4X3ZmZ2dmO2aX;uJIF{e2G7 Mln1O{Bl[Xm| MmTHTY5lfWO2aX;uJI9nKGGmaYDv[4Vv\XOrczDpckBud3W|ZTCzWFNNOSClZXzsd{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDsbZBq\CCjY3P1cZVt[XSrb36gZYZ1\XJiNzDkZZl{KGK7IF;pcEBz\WRiTzDzeIFqdmmwZx?= MYSyNFUzPzl4OR?=
CHO-K1 cells MULGeY5kfGmxbjDhd5NigQ>? MoLpVIFzfGmjbDDh[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYT3MRmQh\XiycnXzd4VlKGmwIFPIU{1MOSClZXzsd{Bkdy22cnHud4Zm[3SnZDD3bZRpKEeDTESgZZN{\XO|ZXSgZZMhdHWlaX\ldoF{\SCjY4Tpeol1gSCkeTD0doFve2GldHn2ZZRqd25iYYPzZZktKEWFNUC9NE4yKM7:TR?= NYjPUWNpOjB3Mke5Olk>
HEK293T cells NWqwN2NGTnWwY4Tpc44h[XO|YYm= MWOxJO69VQ>? NFraVHozPCCqcoO= MmjXVIFzfGmjbDDh[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYT3MRmQh\XiycnXzd4VlKGmwIFjFT|I6O1RiY3XscJMh[XO|ZYPz[YQh[XNiaX7keYN1cW:wIH;mJJJm[2WydH;yJJRz[W6|YXP0bZZifGmxbjDheEAyKHWPIHHmeIVzKDJ2IHjyd{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYm= MX6yNVA{ODJ4Mx?=
CV1 cells Mn64SpVv[3Srb36gZZN{[Xl? MWrUdoFve2GldHn2ZZRqd25ib3[gS4FtPC2odYPl[EBpfW2jbjDQVGFT\2GvbXGgSG5CKGKrbnTpcoch\G:vYXnuJIV5eHKnc4Pl[EBqdiCjZoLpZ4FvKGe{ZXXuJI1wdmuneTDDWlEh[2WubIOgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDFR|UxRTBwMTFOwG0> M{S2V|IyOTF{N{i0
HEK293 cells NWLHdXQ1TnWwY4Tpc44h[XO|YYm= Mo\JNVYhfG9iMkCgbJJ{ MUPUdoFve2GldHn2ZZRqd25ib3[gS4FtPC2odYPl[EBpfW2jbjDQVGFT\2GvbXGg[ZhxemW|c3XkJIlvKEiHS{K5N{Bk\WyuczDh[pRmeiBzNjD0c{AzOCCqcoOgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDFR|UxRTBwMESzJO69VQ>? NUP5[GtzOjFzMki2NFA>
HepG2 cells NH3GZnpHfW6ldHnvckBie3OjeR?= Mon0NVAhfW2xbD;M MX[yOEBpenN? M2jscWlv[3KnYYPlJIlvKGeudXPvd4Uh[2:wc4XtdJRqd25iaX6gbJVu[W5iSHXwS|Ih[2WubIOgZZQhOTBidX3vcE9NKGGodHXyJFI1KGi{czDy[YxifGm4ZTD0c{Bkd262cn;s M2Hl[|IyOjV4N{S4
3T3L1 cell M4DzeGZ2dmO2aX;uJIF{e2G7 NUDUfZI{OSC3TR?= NInrfndKdmS3Y4Tpc44hd2ZibX;1d4UhO1R|TEGgZ4VtdCCmaX\m[ZJmdnSrYYTpc44h[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gZYNkfW23bHH0bY9vKG:oIHnueJJi[2WubIXsZZIhdGmyaXSg[JJweGyndDDheEAyKHWPIHL5JG9qdCC{ZXSgU{B{fGGrbnnu[y=> M1q3ZlIyPDBzMUG4
CV1 cells M{L1bWZ2dmO2aX;uJIF{e2G7 NYHOZpFuPDBiaB?= NWfYUnRmSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEuVEKGIHX4dJJme3OnZDDpckBEXjFiY3XscJMh[29vdILhcpNn\WO2ZXSge4l1cCCJYXy0JIFnfGW{IESwJIhzeyCkeTDseYNq\mW{YYPlJIJie2WmIITyZY5{[WO2aY\heIlwdiCjc4PhfUwhTUN3ME2wMlEh|ryP MmjzNlE2OTVyNkO=
HepG2 cells NYjsfngyTnWwY4Tpc44h[XO|YYm= NF;IfppC\2:waYP0JIFkfGm4aYT5JIF1KFCSQWLnZY1u[SC{ZXPldJRweiCneIDy[ZN{\WRiaX6gbJVu[W5iSHXwS|Ih[2WubIOgZpkhWFCURT3seYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUC9NE4xOSEQvF2= NYD4S3A2OjF2OEK0OFY>
HepG2 cells NFLQT5pHfW6ldHnvckBie3OjeR?= M1Tyb3Rz[W6|YXP0bZZifGmxbjDv[kBpfW2jbjDQVGFT\2GvbXGg[ZhxemW|c3XkJIlvKGi3bXHuJGhmeEd{IHPlcIx{KGOxLYTyZY5{\mWldHXkJJdqfGhiUGDSSVMuXEtvTIXjJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygSWM2OD1yLkC1JO69VQ>? NYLIfJoyOjF2NUC0Olg>
COS7 cells MmHqSpVv[3Srb36gZZN{[Xl? NIHDPGNOd2S3bHH0bY9vKG:oIHj1cYFvKFCSQWLnZY1u[S2OQlSg[ZhxemW|c3XkJIlvKGGocnnjZY4h\3KnZX6gcY9vc2W7IFPPV|ch[2WubIOgZ48ufHKjboPm[YN1\WRid3n0bEBI[Wx2IHHzd4V{e2WmIHHzJIFkfGm4YYTpc44hd2ZidILhcpNi[3SrdnH0bY9vKGGldHn2bZR6KGK7IHz1Z4ln\XKjc3WgZZN{[XluIFXDOVA:OC5yNEOg{txO MX6yNVg4OzB5MB?=
COS-1 cells NX7nfHdTTnWwY4Tpc44h[XO|YYm= NUDqcXFiOjRiaILz MmLLRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFT\2GvbXGgcIlo[W6mIHLpcoRqdmdiZH;tZYlvKGW6cILld5Nm\CCrbjDDU3MuOSClZXzsd{Bi\nSncjCyOEBpenNiYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nLXLhd4VlKGy3bXnuc41mfHKrYzDhcoFtgXOrczygSWM2OD1yLkC0PEDPxE1? MUWyNlA2OTB3NB?=
COS1 cells MW\GeY5kfGmxbjDhd5NigQ>? NYDzenFkOjRiaILz NWDINlY2XHKjboPhZ5RqfmG2aX;uJI9nKGi3bXHuJIZ2dGxibHXu[5RpKFCSQWLnZY1u[SCneIDy[ZN{\WRiaX6gR29UOSClZXzsd{Bkdy22cnHud4Zm[3SnZDD3bZRpKFK[UnHsdIhiKGGodHXyJFI1KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFXDOVA:OC5zMjFOwG0> M2nJZ|IzOTl5M{m2
MG-63 cells NXXzWVljTnWwY4Tpc44h[XO|YYm= NEDqTGdC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iTVetOlMh[2WubIOgZpkhemWyb4L0[ZIh\2WwZT3iZZNm\CC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;MD6wNVEh|ryP MUOyNlIzPTZ2MR?=
COS1 cells NVjLNW9VTnWwY4Tpc44h[XO|YYm= NHjBNnpDcW6maX7nJIFn\mmwaYT5JJRwKGi3bXHuJJdqdGRidInw[UBRWEGUZ3HtcYEhVEKGIHX4dJJme3OnZDDpckBEV1NzIHPlcIx{KGOxLXX4dJJme3OrbnegS2FNPCCkeTDzZ4lvfGmubHH0bY9vKHC{b4jpcYl1gSCjc4PhfS=> MlW2NlIxPzB4MES=
MG-63 cells Mm[4SpVv[3Srb36gZZN{[Xl? MVWyOEBpenN? MWPNc4R2dGG2aX;uJI9nKG[3bHytcIVv\3SqIHj1cYFvKHCVR{Wt[pV{\WRiUGDBVodidW2jIHX4dJJme3OnZDDpckBOTy14MzDj[YxteyClbz3lfJBz\XO|aX7nJJBIXi2SMj3QVHJGKGGodHXyJFI1KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZoF{\WRidILhcpNi[3SrdnH0bY9vKGG|c3H5MEBGSzVyPUCuNFEyKM7:TR?= NFfKfYszOjd{N{S0PC=>
Ac2F cells MnXWSpVv[3Srb36gZZN{[Xl? M1e4elAvOSC2bzCxNEDPxE1? NF\GdpY3KGi{cx?= MlfuRYdwdmm|dDDhZ5Rqfmm2eTDheEBRWEGUZ3HtcYEhcW5icnH0JGFkOkZiY3XscJMh[XO|ZYPz[YQh[XNibIXjbYZmemG|ZTDhZ5Rqfmm2eTDheEAxNjFidH:gNVAhfU1iYX\0[ZIhPiCqcoOgZpkhemWyb4L0[ZIh\2WwZTDhd5NigQ>? M2DDXVIzQDF7MUmw
293H DA cells NHjl[YlHfW6ldHnvckBie3OjeR?= MVuxOkBp NYSzfpFlSWexbnnzeEBi[3Srdnn0fUBifCCSUFHS[4FudWFiTFLEJIlvKGi3bXHuJFI6O0hiRFGgZ4VtdHNiYX\0[ZIhOTZiaILzJIJ6KFSULV\SSXQh[WO2aY\heIlwdiC{ZYDvdpRmeiCjc4PhfUwhTUN3ME2wMlAxOjRizszN NVvXPIhGOjJ3OEK5O|M>
3T3L1 cells NUjJ[XlxTnWwY4Tpc44h[XO|YYm= NF7FOVAyOCC3TR?= MnGyTY5kemWjc3WgbY4h[WSrcH;u[YN1cW5ibWLORUBt\X[nbIOgbY4hXE6IYXzwbIEucW6mdXPl[EBud3W|ZTCzWFNNOSClZXzsd{BxemW2cnXheIVlKGG2IEGwJJVOKGKnZn;y[UBVVkZvYXzwbIEh[2ijbHzlcodmKHKnbHH0bZZmKHSxIHPvcpRzd2x? MV6yNVg2OTB6OR?=
HepG2 cells NIm0TpNHfW6ldHnvckBie3OjeR?= MUCxNEB2VQ>? MUKyOEBp MY\S[YR2[3Srb36gc4Yh\2y3Y3;z[UBkd26|dX3weIlwdiCrbjDpcpN2dGmwLYLld4l{fGGwdDDoeY1idiCKZYDHNkBk\WyuczDheEAyOCC3TTDh[pRmeiB{NDDodpMh[nliZ3z1Z49{\SCxeHnkZZNmKG2ndHjv[EBqdiCycnXz[Y5k\SCxZjCyNk4zKG2PIH;mJIdtfWOxc3W= M1rJZlI{ODJ3MkS0
HepG2 cells NUPOV4hzTnWwY4Tpc44h[XO|YYm= NF\aVXMyOCC3TR?= Ml3qNlQhcA>? MmP1VoVlfWO2aX;uJI9nKGeudXPvd4Uh[2:wc4XtdJRqd25iaX6gbY5{fWyrbj3y[ZNqe3SjboSgbJVu[W5iSHXwS|Ih[2WubIOgZZQhOTBidV2gZYZ1\XJiMkSgbJJ{KGK7IHfseYNwe2Vib4jp[IF{\SCvZYToc4QhcW5icILld4Vv[2Vib3[gNE4yKHWPIH;mJIlve3WuaX6= MoLqNlMxOjV{NES=
THP1 cells NUjpOnB5TnWwY4Tpc44h[XO|YYm= NIjDVVgyODBidV2= M2\GNVMhcHK| M4\CXXRz[W6|YXP0bZZifGmxbjDv[kBRWEGUZ3HtcYEhcW5iaIXtZY4hXEiSMTDj[YxteyCjc4Pld5Nm\CCjczDk[YNz\WG|ZTDpckBNWFNvaX7keYNm\CCPQ2CxJI1TVkFiZYjwdoV{e2mxbjDheEAyODBidV2gdJJmcW6ldXLheIVlKG[xcjCzJIhzeyCycnnvdkB1dyCOUGOgZ4hidGynbnflJI1m[XO3cnXkJIFnfGW{IEG4JIhzeyCkeTDSWE1RS1JiYX7hcJl{cXNicnXsZZRqfmVidH:geY51emWjdHXkJINwdnS{b3y= NYO5bmJVOjJ7M{S1N|c>
THP1 cells MV\GeY5kfGmxbjDhd5NigQ>? MWKxNFAhfU1? MUGzJIhzew>? NX\2fZVMXHKjboPhZ5RqfmG2aX;uJI9nKFCSQWLnZY1u[SCrbjDoeY1idiCWSGCxJINmdGy|IHHzd4V{e2WmIHHzJIRm[3KnYYPlJIlvKEySUz3pcoR2[2WmIFnMOkBuWk6DIHX4dJJme3Orb36gZZQhOTByIIXNJJBz\WmwY4XiZZRm\CCob4KgN{BpenNicILpc5IhfG9iTGDTJINp[WyuZX7n[UBu\WG|dYLl[EBi\nSncjCxPEBpenNiYomgVnQuWEOUIHHuZYx6e2m|IILlcIF1cX[nIITvJJVvfHKnYYTl[EBkd262cn;s MmfJNlI6OzR3M{e=
HepG2 cells MVzGeY5kfGmxbjDhd5NigQ>? M1jxRXRz[W6|YXP0bZZifGmxbjDv[kBISUx2LX\1d4VlKFCSQWLnZY1u[SCuaXfhcoQh[mmwZHnu[{Bld22jaX6geJJidnOoZXP0[YQhcW5iaIXtZY4hUGWyR{KgZ4VtdHNiYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwQVAvOSEQvF2= MoLZNlI6OzR3M{e=
HepG2 cells MULGeY5kfGmxbjDhd5NigQ>? MXOyNEBp NXPnSYd5SWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBISUx2LX\1d4VlKFCSQWLnZY1u[SCuaXfhcoQh[mmwZHnu[{Bld22jaX6g[ZhxemW|c3XkJIlvKEincFeyJINmdGy|IHHmeIVzKDJyIHjyd{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUhfHKjboPhZ5RqfmG2aX;uJIF{e2G7LDDFR|UxRTBwMEKg{txO MmfxNlIxQDF7M{K=
BL21 DE3 cells M2fCSmZ2dmO2aX;uJIF{e2G7 NYC1NWt6TGm|cHzhZ4Vu\W62IH;mJHs{UF2{b4Pp[4xqfGG8b37lJIZzd21iTj30[ZJucW6jbDDIbZMufGGpZ3XkJIh2dWGwIGDQRXJo[W2vYTDsbYdidmRiYnnu[Ilv\yCmb33hbY4h\XiycnXzd4VlKGmwIFXzZ4hmemmlaHnhJINwdGliQlyyNUBFTTNiY3XscJMh[nlic3PpcpRqdGyjdHnvckBxem:6aX3peJkh[XO|YYmsJGtqRTBwMEe0JO69VQ>? NWizcHdlOjJyOEG5N|I>
human L02 cells NFzTTZhHfW6ldHnvckBie3OjeR?= NE\2Um9C\2:waYP0JIFkfGm4aYT5JIF1KFCSQWLnZY1u[S2OQlSg[ZhxemW|c3XkJIlvKGi3bXHuJGwxOiClZXzsd{Bkdy2neIDy[ZN{cW6pIIDHUFMuW1Z2MD3HRWw1KGGodHXyJFI1KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZoF{\WRidILhcpNi[3SrdnH0bY9vKGG|c3H5MEBGSzVyPUCuPUDPxE1? MYOyN|E5PjNyNx?=
HepG2 cells NGfDbFFHfW6ldHnvckBie3OjeR?= M1jKdFIxKGh? NEXy[nNVemGwc3HjeIl3[XSrb36gc4YhT0GOND3meZNm\CCqdX3hckBRWEGUZ3HtcYEhdGmpYX7kJIJqdmSrbneg[I9u[WmwIHX4dJJme3OnZDDpckBJ\XCJMjDj[YxteyCjZoTldkAzOCCqcoOgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDFR|UxRTBwMEO5JO69VQ>? NGf0d4wzOzF5MUC0OS=>
HEK293 cells NEjycWRHfW6ldHnvckBie3OjeR?= MXmxNEDPxE1? NYrJb5RIXHKjboPhZ5RqfmG2aX;uJI9nKFCSQWLnZY1u[SBqdX7rco94diCxcnnnbY4qKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMh[29vdILhcpNn\WO2ZXSge4l1cCCDUEKtVHBTTSCjdDCxNEB2VSCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZk> MkPaNlMzPzN3MUm=
HEK293 cells NGTPe2dHfW6ldHnvckBie3OjeR?= NYrkN3pUSWexbnnzeEBifCCqdX3hckBRWEGUZ3HtcYEhVEKGIHX4dJJme3OnZDDpckBpfW2jbjDISWszQTNiY3XscJMh[2:2cnHud4Zm[3SnZDD3bZRpKEeDTEStUJVkKGG|c3Xzd4VlKGG|IITyZY5{[3KrcITpc45idCCjY4TpeoF1cW:wIHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSxiRVO1NF0xNjByNDFOwG0> MUGyN|I5Pjd6Nx?=
HEK293 cells NX24UZEyTnWwY4Tpc44h[XO|YYm= NFuyNIEzPCCq NWXlTZY6XHKjboPhZ5RqfmG2aX;uJI9nKEeDTESgSGJFNW[3c3XkJIh2dWGwIGDQRXJo[W2vYT3MRmQh\XiycnXzd4VlKGmwIFjFT|I6OyClZXzsd{Bi\nSncjCyOEBpenNiYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwQVAvOSEQvF2= MX2yN|I6PDh|MB?=
HEK293 cells NF\pRZJHfW6ldHnvckBie3OjeR?= MVe0PEBpenN? NVzWWGxzSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIFjFT|I6OyClZXzsd{Bkd3S{YX7z[oVkfGWmIIfpeIghWFCURYi0MXRMNWy3YzDhd5Nme3OnZDDhd{Bi[3SrdnH0bY9vKG:oIHz1Z4ln\XKjc3WgZYN1cX[rdImgcYVie3W{ZXSgZYZ1\XJiNEigbJJ{KGK7IITyZY5{[WO2aY\heIlwdiCjc4PhfUwhTUN3ME20N{44OSEQvF2= Mn7FNlMzPjV6NES=
HepG2 cells NWDZS|AzTnWwY4Tpc44h[XO|YYm= MkPFRYdwdmm|dDDhZ5Rqfmm2eTDheEBISUx2LX\1d4VlKFCSQWLnZY1u[SBqdX7rco94diCxcnnnbY4qKGW6cILld5Nm\CCrbjDoeY1idiCKZYDHNkBk\WyuczDifUB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5yMTFOwG0> M1m3clI{PTB{MkGy
HepG2 cells M{LWXGZ2dmO2aX;uJIF{e2G7 NGjrTHVC\2:waYP0JIFkfGm4aYT5JIF1KEeDTESt[pV{\WRiUGDBVodidW2jIF20OlNCKG23dHHueEApfW6tbn;3ckBwemmpaX6pJIV5eHKnc4Pl[EBqdiCqdX3hckBJ\XCJMjDj[YxteyCkeTD0doFve2GldHn2ZZRqd25iYYPzZZktKEWFNUC9NE4xODJizszN NX;qdHdmOjN3MEKyNVI>
L6 cells NXXqb5NiTnWwY4Tpc44h[XO|YYm= MXuyOEBpenN? NXeybFFsUW6mdXP0bY9vKG:oIHfseYNwe2VidYD0ZYtmKGmwIILheEBNPiClZXzsd{BxfWy|ZXSge4l1cCCFMUSt[IVwgHliZ3z1Z49{\SCjZoTldkAzPCCqcoOgbY4heHKnc3XuZ4Uhd2ZiaX7zeYxqdixiRVO1NF01NjR7IN88US=> MYOyN|k6Ojh4Mh?=
L6 cells NUe3PXR[TnWwY4Tpc44h[XO|YYm= MoHrNVYhcHK| M2rPd2lv[3KnYYPlJIlvKDJvW{PIYU1l\W:6eXfseYNwe2VidYD0ZYtmKGmwIILheEBNPiClZXzsd{Bi\nSncjCxOkBpenNiYomgd4NqdnSrbHzheIlwdiClb4XueIlv\yCjbnHsfZNqeyxiRVO1NF01NjhizszN MVKyOFgyOzd|OB?=
DU145 cells MUjDfZRwfG:6aXPpeJkh[XO|YYm= MUO0PEBpenN? NX;iRlRVS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hTFVzNEWgZ4VtdHNiYYPz[ZN{\WRiYYOg[5Jwf3SqIHnubIljcXSrb36gZYZ1\XJiNEigbJJ{KGK7IF3UWEBie3OjeTygSWM2OD1zNjFOwG0> M4nuOFI1QTl4MUSz
PC3 cells NHTVVHREgXSxdH;4bYNqfHliYYPzZZk> MWS0PEBpenN? MoLQR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gVGM{KGOnbHzzJIF{e2W|c3XkJIF{KGe{b4f0bEBqdmirYnn0bY9vKGGodHXyJFQ5KGi{czDifUBOXFRiYYPzZZktKEWFNUC9NlAvOyEQvF2= NYD4SZZuOjR7OU[xOFM>
MDA-MB-231 cells Moj3S5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? NH7oPY4zPCCqcoO= NGjxd3JIem:5dHigbY5pcWKrdHnvckBw\iCqdX3hckBOTEFvTVKtNlMyKGOnbHzzJIFnfGW{IEK0JIhzeyCkeTDNWHQh[XO|YYmsJGVEPTB;NT6yN{DPxE1? M4jKTVI2Ojd6MkO2
HEK293 cells NXSx[VZtTnWwY4Tpc44h[XO|YYm= M4fVfmFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hJIV5eHKnc4Pl[EBqdiCKRVuyPVMh[2WubIOgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDFR|UxRTBwMEGg{txO MVeyOVMxPTZ6OB?=
HepG2 cells MkjsSpVv[3Srb36gZZN{[Xl? M4GySFIxKGi{cx?= NUDnfoR4XHKjboPhZ5RqfmG2aX;uJI9nKFCSQWKgeJJidnOoZXP0[YQhcW5iaIXtZY4hUGWyR{KgZ4VtdHNiYX\0[ZIhOjBiaILzJIJ6KFCSQWKtcJVkcW[ncnHz[UBie3OjeTygSWM2OD1zLk[g{txO MmfGNlU1Ozd|MES=
HEK293 cells MWHGeY5kfGmxbjDhd5NigQ>? NUfWfXR{OjRiaILz M1HtbHRz[W6|YXP0bZZifGmxbjDv[kBRWEGUZ3HtcYEhMHWwa37ve44hd3KrZ3nuLUBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzJIlv[3WkYYTl[EBnd3JiMkSgbJJ{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfS=> NFThTIYzPTR2MkOyNi=>
HepG2 cells MXfGeY5kfGmxbjDhd5NigQ>? NUToRnAySWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBISUx2LWDQRXJo[W2vYTDsbYdidmRiYnnu[Ilv\yCmb33hbY4h\XiycnXzd4VlKGmwIHj1cYFvKEincFeyJINmdGy|IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSxiRVO1NF0xNjB|OTFOwG0> NHnKPXYzPTR4MkK4NS=>
HEK293 cells NYmxVog4TnWwY4Tpc44h[XO|YYm= NVTwcZpUOjRiaILz NU\6fGZSSWexbnnzeEBi[3Srdnn0fUBifCCvb4Xz[UBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIFjFT|I6OyClZXzsd{Bkdy2neIDy[ZN{cW6pIIfpeIghT2GuNDDy[ZBwenSncjD2[YN1d3JiYX\0[ZIhOjRiaILzJIJ6KGS3YXytcJVkcW[ncnHz[UBz\XCxcoTldkBie3OjeTygSWM2OD1yLkCzJO69VQ>? NWj2NYVGOjR7NUW4PFk>
HepG2 cells M4KxZWZ2dmO2aX;uJIF{e2G7 NGC2SW0zOCCqcoO= MkLCRYdwdmm|dDDhZ5Rqfmm2eTDheEBISUx2LVTORUBjcW6maX7nJIRwdWGrbjDmeZNm\CCqdX3hckBRWEGUZ3HtcYEhdGmpYX7kJIJqdmSrbneg[I9u[WmwIHX4dJJme3OnZDDpckBpfW2jbjDI[ZBIOiClZXzsd{Bie3Onc4Pl[EBieyC{ZXPldJRweiC2cnHud4FkfGm4YYTpc44hcW6ldXLheIVlKG[xcjCyNEBpenNiYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwQVAvODRizszN M2nHdVI2PDl5MUOy
HepaR cells Ml3PSpVv[3Srb36gZZN{[Xl? MlnVNUBl[Xl? M1;iT2Fod26rc4SgZYN1cX[rdImgZZQhWFCDUnfhcY1iKGmwIHj1cYFvKEincHHSJINmdGy|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKEiPR1PTNkBo\W6nIHX4dJJme3Orb36gZZQhOSC3TTDpcoN2[mG2ZXSg[o9zKDFiZHH5JIJ6KHG3YX70bZRifGm4ZTDQR3IhdWW2aH;kJJJmdGG2aY\lJJRwKHWwdILlZZRm\CClb370do9t NVnEW|hROjV2OUexN|I>
HepaR cells Mne4SpVv[3Srb36gZZN{[Xl? NXTRV3Y6OSC3TR?= MoOzNUBl[Xl? MmjaRYdwdmm|dDDhZ5Rqfmm2eTDheEBRWEGUZ3HtcYEhcW5iaIXtZY4hUGWyYWKgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5kemWjc3WgbY4hSU6JUGTMOEBo\W6nIHX4dJJme3Orb36gZZQhOSC3TTDpcoN2[mG2ZXSg[o9zKDFiZHH5JIJ6KHG3YX70bZRifGm4ZTDQR3IhdWW2aH;kJJJmdGG2aY\lJJRwKHWwdILlZZRm\CClb370do9t MoraNlU1QTdzM{K=
HepaR cells MYfGeY5kfGmxbjDhd5NigQ>? NF\PcnQyKHWP MkXLNUBl[Xl? NH22dGVC\2:waYP0JIFkfGm4aYT5JIF1KFCSQWLnZY1u[SCrbjDoeY1idiCKZYDhVkBk\WyuczDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiCIQVLQNUBo\W6nIHX4dJJme3Orb36gZZQhOSC3TTDpcoN2[mG2ZXSg[o9zKDFiZHH5JIJ6KHG3YX70bZRifGm4ZTDQR3IhdWW2aH;kJJJmdGG2aY\lJJRwKHWwdILlZZRm\CClb370do9t NXrZemllOjV2OUexN|I>
HEK293 cells MWfGeY5kfGmxbjDhd5NigQ>? MoHjNVAh|ryP MnjVNlQhcHK| NVfEbJJ3XHKjboPhZ5RqfmG2aX;uJI9nKFCSQWKt[4FudWFiKIXub45wf25ib4Lp[4lvMSCneIDy[ZN{\WRiaX6gTGVMOjl|IHPlcIx{KGG2IEGwJJVOKGGodHXyJFI1KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[Xl? NVPhS2d5OjR6OUCwPVA>
C2C12 cells NHjDUoNHfW6ldHnvckBie3OjeR?= M{PCOFMxKM7:TR?= MUWyJIg> NGK3XnRKdmS3Y4Tpc44hd2ZiMj3k[Y95gS2dM1jdMYdtfWOxc3WgeZB1[WunIHnuJI1wfXOnIFOyR|EzKGOnbHzzJIF1KDNyIIXNJIFnfGW{IEKgbJJ{KGK7IHzpdZVq\CC|Y3nueIltdGG2aX;uJINwfW62aX7nJIFv[Wy7c3nz MV[yOVg{PTV|Nx?=
MCF7 cells NYHjTZVPTnWwY4Tpc44h[XO|YYm= M{fCTVE3KGh? MXXB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYTD0doFve2[nY4Tl[EBqdiCqdX3hckBOS0Z5IHPlcIx{KGGodHXyJFE3KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFXDOVA:OC5yOEeg{txO MX:yOlIzPjR7MB?=
HEK293 cells M3jvOmZ2dmO2aX;uJIF{e2G7 NEnxWJMyOCEQvF2= M17POVI1KGh? MV;B[49vcXO2IHHjeIl3cXS7IHH0JHBRSVKpYX3tZUApfW6tbn;3ckBwemmpaX6pJIV5eHKnc4Pl[EBqdiCKRVuyPVMh[2WubIOgZZN{\XO|ZXSgZZMhemWlZYD0c5IhfHKjboPhZ5RqfmG2aX;uJIF1KDFyIIXNJIlv[3WkYYTl[EBnd3JiMkSgbJJ{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfS=> NFvQ[IEzPjN6NEK4Oi=>

... Click to View More Cell Line Experimental Data

Protocol

References

Solubility (25°C)

In vitro DMSO 35 mg/mL (198.67 mM)
Ethanol 35 mg/mL (198.67 mM)
Water Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 176.17
Formula

C10H8O3

CAS No. 90-33-5
Storage powder
in solvent
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT00225537 Unknown status Chronic Hepatitis C|Chronic Hepatitis B MTmedical Institute of Health|The University of Texas Health Science Center at San Antonio|BioMonde Preparations Limited September 2005 Phase 2
NCT00225537 Unknown status Chronic Hepatitis C|Chronic Hepatitis B MTmedical Institute of Health|The University of Texas Health Science Center at San Antonio|BioMonde Preparations Limited September 2005 Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Related Others Products0

Tags: buy 4-Methylumbelliferone (4-MU) | 4-Methylumbelliferone (4-MU) supplier | purchase 4-Methylumbelliferone (4-MU) | 4-Methylumbelliferone (4-MU) cost | 4-Methylumbelliferone (4-MU) manufacturer | order 4-Methylumbelliferone (4-MU) | 4-Methylumbelliferone (4-MU) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID